Romania’s interim government has allocated an additional € 66.5 million (329 million RON) from its reserve fund to support the health sector hit by COVID. These funds will be used to support national health programs, the procurement of antiviral drugs and vaccines.
In addition to the COVID-19 vaccine, vaccines against influenza, human papillomavirus and hexavalent vaccines (against diphtheria, hepatitis B, pertussis, tetanus, poliomyelitis and invasive diseases caused by Haemophilus influenzae type b) will be purchased. It is also expected to purchase 70,000 vials of Remdesivir (an antiviral drug) to ensure a stable drug supply and continuity of treatment for COVID patients in hospitals across Romania. Also, according to Minister of Health Cseke Attila, the additional funds will be used to replenish the number of food vouchers for people taking the COVID-19 vaccine.
These additional funds were added to the two previous budget increases. The first occurred at the end of September 2021, when additional funds were allocated from the state budget for the purchase of drugs for COVID patients and support for intensive care programs. The second budget increase took place in October 2021 to purchase sera for the national vaccination program. These successive budget increases were necessary to support the Romanian health care system amid hospital congestion with coronavirus patients.
For further information, please contact Jane Smith at Grove Group Pharmaservices firstname.lastname@example.org or visit our website www.groveonline.com